REVIVA PHARMACEUTICALS HOLDI (RVPH:NASDAQ)
$0.6839 -0.0761 (-10.0132%)
Analysed REVIVA PHARMACEUTICALS HOLDI (RVPH:NASDAQ) News Sources
Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights
30-03-2026
yahoo.com
RVPH: Cleared for Takeoff – 2Q:26 Initiation of RECOVER 2
01-04-2026
yahoo.com
Does Cobenfy Have the Potential to Become a Top Drug for BMY?
09-04-2026
yahoo.com
Reviva Announces Letter to Shareholders
15-04-2026
yahoo.com
RVPH: Shareholder Letter Introduces New IP
20-04-2026
yahoo.com
Maxim Turns Cautious on Reviva Pharmaceuticals Holdings, Inc. (RVPH) Despite Phase 3 Progress Plans
21-04-2026
yahoo.com
Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications
23-04-2026
yahoo.com
Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights
13-05-2026
yahoo.com
Reviva to Participate in Fireside Chat at A.G.P.’s Annual Healthcare Company Showcase
18-05-2026
yahoo.com
RVPH: First Quarter 2026 Results
27-05-2026
yahoo.com
What is the current price of REVIVA PHARMACEUTICALS HOLDI (RVPH:NASDAQ)?
The current price of REVIVA PHARMACEUTICALS HOLDI (RVPH:NASDAQ) is $0.6839.
REVIVA PHARMACEUTICALS HOLDI (RVPH:NASDAQ) absolute price change since previous trading day?
The absolute price change of REVIVA PHARMACEUTICALS HOLDI (RVPH:NASDAQ) since the previous trading day is $-0.0761.
REVIVA PHARMACEUTICALS HOLDI (RVPH:NASDAQ) percentage price change since previous trading day?
The percentage price change of REVIVA PHARMACEUTICALS HOLDI (RVPH:NASDAQ) since the previous trading day is -10.0132%.
What is the most recent average sentiment score for REVIVA PHARMACEUTICALS HOLDI (RVPH:NASDAQ)?
The most recent average sentiment score for REVIVA PHARMACEUTICALS HOLDI (RVPH:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for REVIVA PHARMACEUTICALS HOLDI (RVPH:NASDAQ)?
The most recent sentiment for REVIVA PHARMACEUTICALS HOLDI (RVPH:NASDAQ) is .
SEC-8K** Filing Available For REVIVA PHARMACEUTICALS HOLDI (RVPH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.